Location of bile leak predicts the success of ERCP performed for postoperative bile leaks

Gastrointest Endosc. 2013 Apr;77(4):601-8. doi: 10.1016/j.gie.2012.11.026. Epub 2013 Jan 26.

Abstract

Background: ERCP is effective for treating a bile leak (BL) after cholecystectomy (CCY), but few data exist on its effectiveness after hepatobiliary surgery (HBS).

Objective: To determine the effectiveness of ERCP for treating BLs after HBS compared with BLs after cholecystectomy and to identify factors associated with treatment success.

Design: Retrospective cohort.

Setting: Academic tertiary-care referral center.

Patients: Patients referred from 2001 to 2009 for ERCP treatment of BL after cholecystectomy or HBS.

Interventions: ERCP.

Main outcome measurements: Resolution of BL after a single ERCP.

Results: A total of 223 patients were identified and 46 were excluded. Fifty underwent ERCP for treatment of BL after HBS and 127 after CCY. A single ERCP was successful at resolving BL in 89% of patients. Failure occurred in 7 HBS patients (14%) and 12 CCY patients (9%) (P = .379). After multiple ERCPs, success improved to 95% of the CCY group and 86% of the HBS group (P = .033). HBS patients underwent 30% more ERCPs (P = .049). ERCP was 3.3 times more likely to be successful in patients with cystic duct or duct of Luschka BLs (P = .028). Patients undergoing biliary stent placement were significantly more likely to have successful outcomes (odds ratio 71.0, P < .001). Surgical history or biliary sphincterotomy did not affect outcome. Odds of treatment failure were 3.5 times higher for each additional ERCP performed (P < .001).

Limitations: Single-center, retrospective study.

Conclusions: ERCP is effective for treating postoperative BLs. Location of a BL and placement of a biliary stent are the best predictors of endoscopic treatment success.

MeSH terms

  • Anastomotic Leak / surgery*
  • Bile*
  • Cholangiopancreatography, Endoscopic Retrograde*
  • Cholecystectomy / adverse effects*
  • Cohort Studies
  • Female
  • Humans
  • Liver Transplantation / adverse effects*
  • Male
  • Middle Aged
  • Prognosis
  • Remission Induction
  • Retrospective Studies